Loading…
Remedium Lifecare (BSE 539561)₹0.27000.00%Trading & Distributors
At the end of the Dec 2025 quarter, Remedium Lifecare's shareholders were: promoters 1.14%, FIIs 1.68%, public 97.18%. Promoter holding is unchanged on the quarter. FII holding is up 1.68 percentage points from 0.00% a year earlier. 0.00% of promoter shares were pledged. It had 1,11,304 shareholders.
As of · Company filings (shareholding pattern)
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 1.12% | 1.12% | 1.12% | 1.12% | 1.12% | 1.12% | 1.12% | 1.12% | 1.12% | 1.14% | 1.14% | 1.14% |
| FIIs | 0.00% | 0.04% | 0.08% | 0.04% | 0.04% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.68% |
| Public | 98.88% | 98.84% | 98.80% | 98.84% | 98.84% | 98.88% | 98.88% | 98.88% | 98.88% | 98.86% | 98.86% | 97.18% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 706 | 1,731 | 3,989 | 3,860 | 15,592 | 26,472 | 67,425 | 73,660 | 1,10,456 | 1,13,578 | 1,14,155 | 1,11,304 |
| Holder | Category | Dec 2025 | Change (pp) |
|---|---|---|---|
| Uppinangady Sudhindra Nayak | Public | 3.19% | 0.00 |
| Manju Devi | Public | 2.44% | New |
| L7 Hitech Private Limited | Public | 2.35% | +0.58 |
| Kamal Asnani | Public | 2.21% | +1.09 |
| Zeta Global Funds (Oeic) Pcc Limited-Zeta Series B Fund Pc | FII | 1.69% | New |
| Comfort Capital Private Limited | Public | 1.67% | +0.16 |
| Randeep Singh | Public | 1.23% | New |
| Siddharth Chimanlal Shah | Promoter | 1.14% | 0.00 |
| Vignesh Prabhu Hejamadi | Public | 1.07% | 0.00 |
| Krishna Kumar Goyal | Public | 1.07% | New |
| Sahay Investment Services | Public | Exited | — |
| Arya Worldwide | Public | Exited | — |
| Prakash Lalchandani | Public | Exited | — |
Promoters held 1.14% of Remedium Lifecare at the end of the Dec 2025 quarter, up 0.02 percentage points from 1.12% a year earlier.
In the Dec 2025 quarter, foreign institutional investors (FIIs) held 1.68% (up 1.68 percentage points from 0.00% a quarter earlier) and domestic institutions (DIIs) held no reported stake.
No. The Dec 2025 filing shows no pledged promoter shares.
Remedium Lifecare had 1,11,304 shareholders at the end of the Dec 2025 quarter, against 73,660 a year earlier.
Uppinangady Sudhindra Nayak (Public) held 3.19% at the end of the Dec 2025 quarter, the largest named holding outside the promoter group.